UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
63 hedge funds and large institutions have $99.7M invested in Unity Biotechnology in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
37% less capital invested
Capital invested by funds: $157M → $99.7M (-$57.8M)
Holders
63
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.12M | |
| 2 | +$1.13M | |
| 3 | +$814K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$778K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$644K |
Top Sellers
| 1 | -$6.07M | |
| 2 | -$1.53M | |
| 3 | -$956K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$392K |
| 5 |
Morgan Stanley
New York
|
-$231K |